The effect of GLP-1 receptor agonists on targets for cardiovascular risk reduction

被引：0
|
作者：
Westrick, Christopher [1 ]
Snider, Melissa [1 ]
Arradaza, Nicole [1 ]
Sharma, Kavita [1 ]
机构：
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
来源：
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
27
引用
收藏
页码：E190 / E190
页数：1
相关论文
共 50 条
  • [1] GLP-1 Receptor Agonists: Effects on Cardiovascular Risk Reduction
    Lorber, Daniel
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (04) : 238 - 249
  • [2] Cardiovascular Risk Reduction by GLP-1 Receptor Agonists in the Asian and white Population
    Kahl, S.
    DIABETOLOGIE, 2025,
  • [3] GLP-1 receptor agonists and cardiovascular protection: A class effect or not?
    Scheen, Andre J.
    DIABETES & METABOLISM, 2018, 44 (03) : 193 - 196
  • [4] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155
  • [5] Cardiovascular safety and GLP-1 receptor agonists
    Carty, David M.
    Drummond, Russell
    Fisher, Miles
    PRACTICAL DIABETES, 2013, 30 (06) : 242 - 245
  • [6] GLP-1 receptor agonists and cardiovascular safety
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S20 - S20
  • [7] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [8] GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
    Marx, Nikolaus
    Husain, Mansoor
    Lehrke, Michael
    Verma, Subodh
    Sattar, Naveed
    CIRCULATION, 2022, 146 (24) : 1882 - 1894
  • [9] GLP-1 receptor agonists: fighting obesity with an eye to cardiovascular risk
    Liuzzo, Giovanna
    Galiuto, Leonarda
    EUROPEAN HEART JOURNAL, 2021, 42 (17) : 1652 - 1653
  • [10] GLP-1 receptor agonists and cardiovascular risk in routine clinical practice
    Schernthaner, Guntram
    Schernthaner-Reiter, Marie Helene
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (02): : 78 - 80
12345